Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Prostatic Neoplasms × Atorvastatin × Clear all

Phase

Status

Completed 4 Withdrawn 2 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Heart Failure 1 Colorectal Neoplasms 1 Cardiotoxicity 1 Breast Cancer Female 1

Interventions

Docetaxel 18 Radiosurgery 17 Radiotherapy 14 Androgen Antagonists 14 Leuprolide 11 bicalutamide 9 Goserelin 9 enzalutamide 8 Surveys and Questionnaires 8 Radiotherapy, Intensity-Modulated 7 Prednisone 7 Blood Specimen Collection 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Gonadotropin-Releasing Hormone 6 Triptorelin Pamoate 5 Multiparametric Magnetic Resonance Imaging 5 Brachytherapy 5 Abiraterone Acetate 5 Standard of Care 4 Positron Emission Tomography Computed Tomography 4 Metformin 4 Heavy Ion Radiotherapy 4 Exercise 4 Estramustine 4 pembrolizumab 3 luprolide acetate gel depot 3 darolutamide 3 cabazitaxel 3 abiraterone 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04026230 2022-10-21

ESTO2

Tampere University Hospital

Phase 3 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡